International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study

NCT04330963 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-04-20

No results posted yet for this study

Summary

Swiss Primary Hypersomnolence and Narcolepsy Cohort Study (SPHYNCS) is a cohort study on disease presentation and long-term course with an exploratory approach to detect biomarkers.

Conditions

  • Narcolepsy
  • Idiopathic Hypersomnia
  • Hypersomnolence Disorder

Sponsors & Collaborators

  • Klinik Barmelweid

    collaborator OTHER
  • Zentrum für Schlafmedizin Basel

    collaborator UNKNOWN
  • Ospedale Regionale di Lugano

    collaborator OTHER
  • Cantonal Hospital of St. Gallen

    collaborator OTHER
  • Zurzach Care Klinik für Schlafmedizin

    collaborator UNKNOWN
  • University Children's Hospital, Zurich

    collaborator OTHER
  • University Children's Hospital Basel

    collaborator OTHER
  • Centre Lausannios de Sommeil

    collaborator UNKNOWN
  • Private Universität Witten-Herdecke and Orfea Fachklinik für Schlafmedizin, Witten, Germany

    collaborator UNKNOWN
  • Leiden University Medical Center, Leiden, Netherlands

    collaborator UNKNOWN
  • University of Bologna, Bologna, Italy

    collaborator UNKNOWN
  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Claudio L Bassetti, Prof. · Insel Gruppe

Eligibility

Min Age
10 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-06
Primary Completion
2024-12-30
Completion
2026-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04330963 on ClinicalTrials.gov